Literature DB >> 4451352

Enhancement of the effects of anti-staphylococcal antibiotics by aminoglycosides.

C Watanakunakorm, C Glotzbecker.   

Abstract

The in vitro activity of seven anti-staphylococcal antibiotics alone and in combination with four aminoglycoside antibiotics against 35 clinical isolates of Staphylococcus aureus from blood cultures of patients with endocarditis or septicemia was studied. The combination of nafcillin-gentamicin or nafcillin-tobramycin when compared with nafcillin alone killed significantly more S. aureus at 6 h for 33 of 35 isolates. A significant decrease in viable colony-forming units at 24 and 48 h was demonstrated for a smaller number of isolates. Using the agar dilution antibiotic susceptibility test, significant enhancement of activity was demonstrated against almost all isolates when cephalothin, cefazolin, or clindamycin was combined with gentamicin, tobramycin, or kanamycin. The combination of nafcillin or vancomycin with gentamicin, tobramycin, or kanamycin also showed enhanced activity against the majority of isolates. Oxacillin or methicillin when combined with the aminoglycosides showed enhancement of activity against the least number of isolates. Streptomycin was the least effective of the four aminoglycoside antibiotics studied.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4451352      PMCID: PMC444739          DOI: 10.1128/AAC.6.6.802

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  UNMASKING OF FALSE-NEGATIVE BLOOD CULTURES IN PATIENTS RECEIVING NEW PENICILLINS.

Authors:  J CARLETON; M HAMBURGER
Journal:  JAMA       Date:  1963-10-12       Impact factor: 56.272

2.  Fifteen years' experience with staphylococcus septicemia in a large city hospital; analysis of fifty-five cases in the Cincinnati General Hospital 1940 to 1954.

Authors:  R WILSON; M HAMBURGER
Journal:  Am J Med       Date:  1957-03       Impact factor: 4.965

3.  Therapy of experimental staphylococcal infection with antibiotic combinations.

Authors:  M E Campos; S Rabinovich; I M Smith
Journal:  J Lab Clin Med       Date:  1974-02

Review 4.  The changing pattern of bacterial endocarditis.

Authors:  S Rabinovich; I M Smith; L E January
Journal:  Med Clin North Am       Date:  1968-09       Impact factor: 5.456

5.  Some salient features of Staphylococcus aureus endocarditis.

Authors:  C Watanakunakorn; J S Tan; J P Phair
Journal:  Am J Med       Date:  1973-04       Impact factor: 4.965

6.  Diagnostic difficulties of staphylococcal endocarditis in geriatric patients.

Authors:  C Watanakunakorn; J S Tan
Journal:  Geriatrics       Date:  1973-05

7.  Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci.

Authors:  C Watanakunakorn; C Bakie
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

  7 in total
  21 in total

1.  Use of synergistic antibiotics in the treatment of infections.

Authors:  J Righter; H Richardson
Journal:  Can Med Assoc J       Date:  1978-11-04       Impact factor: 8.262

2.  Staphylococcal myositis in a compromised host. Successful treatment with the synergistic combination of nafcillin and gentamicin.

Authors:  G W Jordan; R Bauer; G A Wong; A L Barry
Journal:  West J Med       Date:  1976-02

3.  Enhancement of antistaphylococcal activity of nafcillin and oxacillin by sisomicin and netilmicin.

Authors:  C Watanakunakorn; C Glotzbecker
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

4.  Variation in the susceptibility of strains of Staphylococcus aureus to oxacillin, cephalothin, and gentamicin.

Authors:  C G Mayhall; G Medoff; J J Marr
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

5.  Plasmid-mediated resistance to gentamicin in Staphylococcus aureus.

Authors:  D O Wood; M J Carter; G K Best
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

Review 6.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

7.  Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.

Authors:  H H Houlihan; R C Mercier; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

8.  Abbreviated therapy for right-sided Staphylococcus aureus endocarditis in injecting drug users: the time has come?

Authors:  M J DiNubile
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

9.  Value of serum tests in combined drug therapy of endocarditis.

Authors:  T A Drake; C J Hackbarth; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

10.  Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin.

Authors:  L Coppens; B Hanson; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.